Does REMDESIVIR Cause Therapy non-responder? 63 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Therapy non-responder have been filed in association with REMDESIVIR (Veklury). This represents 0.6% of all adverse event reports for REMDESIVIR.
63
Reports of Therapy non-responder with REMDESIVIR
0.6%
of all REMDESIVIR reports
19
Deaths
13
Hospitalizations
How Dangerous Is Therapy non-responder From REMDESIVIR?
Of the 63 reports, 19 (30.2%) resulted in death, 13 (20.6%) required hospitalization, and 19 (30.2%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REMDESIVIR. However, 63 reports have been filed with the FAERS database.
What Other Side Effects Does REMDESIVIR Cause?
Off label use (1,092)
Alanine aminotransferase increased (1,047)
Death (808)
Aspartate aminotransferase increased (713)
Bradycardia (652)
Acute kidney injury (605)
Covid-19 (570)
Drug ineffective (497)
Liver function test increased (447)
Respiratory failure (394)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which REMDESIVIR Alternatives Have Lower Therapy non-responder Risk?
REMDESIVIR vs REMERON
REMDESIVIR vs REMICADE
REMDESIVIR vs REMIFENTANIL
REMDESIVIR vs REMIMAZOLAM
REMDESIVIR vs REMODULIN